# KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP

> **NCT03474991** · PHASE3 · COMPLETED · sponsor: **Julia Bielicki** · enrollment: 510 (actual)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DRUG:** Celestamine®

## Key facts

- **NCT ID:** NCT03474991
- **Lead sponsor:** Julia Bielicki
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-28
- **Primary completion:** 2024-03-26
- **Final completion:** 2024-03-26
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2025-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03474991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03474991, "KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03474991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*